BREAST NEOPLASMS, TRIPLE-NEGATIVE

Clinical trials for BREAST NEOPLASMS, TRIPLE-NEGATIVE explained in plain language.

Never miss a new study

Get alerted when new BREAST NEOPLASMS, TRIPLE-NEGATIVE trials appear

Sign up with your email to follow new studies for BREAST NEOPLASMS, TRIPLE-NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

Needle-in-Tumor cancer therapy seeks to rally Body's defenses

Disease control Not yet recruiting

This study is testing an experimental drug called N17350 for adults with advanced solid tumors that have spread or stopped responding to standard treatments. The drug is injected directly into a tumor every two weeks to try to stimulate the immune system to fight the cancer. The …

Matched conditions: BREAST NEOPLASMS, TRIPLE-NEGATIVE

Phase: PHASE1, PHASE2 • Sponsor: Onchilles Pharma Inc • Aim: Disease control

Last updated Mar 24, 2026 12:03 UTC

BREAST NEOPLASMS, TRIPLE-NEGATIVE

Get alerted when new BREAST NEOPLASMS, TRIPLE-NEGATIVE trials appear

Needle-in-Tumor cancer therapy seeks to rally Body's defenses